Your browser doesn't support javascript.
loading
Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood.
Liu, Z; Martin, J; Orme, L; Seddon, B; Desai, J; Nicholls, W; Thomson, D; Porter, D; McCowage, G; Underhill, C; Cranswick, N; Michael, M; Zacharin, M; Herschtal, A; Sivasuthan, J; Thomas, D M.
Afiliação
  • Liu Z; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia. liuzhengfin@gmail.com.
  • Martin J; Clinical Pharmacology and Department of Medicine, The Royal Children's Hospital, Melbourne, Australia. liuzhengfin@gmail.com.
  • Orme L; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
  • Seddon B; Division of Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
  • Desai J; Royal Children's Hospital, Brisbane, QLD, Australia.
  • Nicholls W; University College London Hospital, London, UK.
  • Thomson D; Division of Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
  • Porter D; Brisbane Children's Hospital, Brisbane, QLD, Australia.
  • McCowage G; Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Underhill C; Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Cranswick N; Starship Children's Hospital, Auckland, New Zealand.
  • Michael M; Children's Hospital Westmead, Sydney, NSW, Australia.
  • Zacharin M; Border Medical Oncology, Albury-Wodonga, VIC, Australia.
  • Herschtal A; Clinical Pharmacology and Department of Medicine, The Royal Children's Hospital, Melbourne, Australia.
  • Sivasuthan J; Division of Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
  • Thomas DM; Clinical Pharmacology and Department of Medicine, The Royal Children's Hospital, Melbourne, Australia.
Cancer Chemother Pharmacol ; 82(5): 887-898, 2018 11.
Article em En | MEDLINE | ID: mdl-30206658

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Caracteres Sexuais / Antibióticos Antineoplásicos / Modelos Biológicos / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Pregnancy Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Caracteres Sexuais / Antibióticos Antineoplásicos / Modelos Biológicos / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Pregnancy Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália